Stockreport

Orgenesis Announces Co-Development Agreement with Accellix

Orgenesis Inc.  (ORGS) 
NASDAQ:AMEX Investor Relations: orgenesis.com
PDF GERMANTOWN, Md., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a leading cell and gene therapy enabling company provi [Read more]